Timothy Goodnow

Tim Goodnow is the President and Chief Executive Officer at Senseonics, Inc.

Tim joined the Senseonics Board of Directors in December 2010 and in March 2011 was named President & CEO. Tim has been instrumental in commercializing the first 90-day Eversense CGM System in Europe and the 180-day product - Eversense XL - which is now distributed in more than 15 countries. He also successfully launched Eversense in the U.S. only 40 days after FDA approval. Tim continues to drive innovation, product development, and new technology for future CGM systems.

Prior to Senseonics, Tim was Vice President of Technical Operations at Abbott Diabetes Care. He also held executive positions at TheraSense, Verax Biomedical, Dade Behring, and Baxter Healthcare.

Tim earned his Ph.D. and Bachelor of Science degree in Chemistry at the University of Miami.